Giroctocogene fitelparvovec

DB16174Investigational

Giroctocogene fitelparvovec is under investigation in clinical trial NCT04370054 (Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia a Adults).

Mechanism: Pharmacologically active on Coagulation factor VIII
Curator reviewed
Also known as: Aav2/6-b-domain-deleted blood coagulation factor viii · Dna (recombinant adeno-associated virus 6 vector pf-07055480 human b-domain-deleted blood-coagulation factor viii-specifying)
Code names: PF-07055480 · SB-525

Resolves to

Compound

UNIIC43ZSD4HNVCAS2166101-71-7

Targets

P00451F8

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Giroctocogene fitelparvovec, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account